Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis.

ABSTRACT:

Background

COVID-19 superinfection by Aspergillus (COVID-19-associated aspergillosis, CAPA) is increasingly observed due to increased awareness and use of corticosteroids. The aim of this study is to compare clinical and imaging features between COVID-19 patients with and without associated pulmonary aspergillosis.

Material and methods

In this case-control study, hospitalized patients between March 2020 and March 2021 were evaluated. Two observers independently compared 105 chest CTs of 52 COVID-19 patients without pulmonary aspergillosis to 40 chest CTs of 13 CAPA patients. The following features were evaluated: lung involvement, predominant main pattern (ground glass opacity, crazy paving, consolidation) and additional lung and chest findings. Chronological changes in the

SUBMITTER: Fischer T 

PROVIDER: S-EPMC9140144 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature